ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683556 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683556; 2) Community: the network communities that were significantly associated with the response to NSC 683556; 3) Molecule: the relationships between components within communities and NSC 683556; 4) MDR: the compounds that were significantly associated with the NSC 683556.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 0.0209467683758286 0.84027977
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0209467683758286 0.076038979
NSC 638441 Null 0.0209467683758286 0.5873932
NSC 639174 Camptothecin Derivative 0.0209467683758286 0.83869003
NSC 644960 Null 0.0209467683758286 0.6166741
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.0209467683758286 0.4863196
NSC 668523 N,N-bis(2-chloropropyl)-N-methylammonium chloride 0.0209467683758286 0.53592072
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.0209467683758286 0.70338147
NSC 676536 2,5-bis(3-Amino-2,4,6-trinitrophenyl)-1,3,4-thiadiazole 0.0209467683758286 0.20624702
NSC 679795 Null 0.0209467683758286 0.056390745
Total:51  Current:22    [First] [Prev] [Next] [Last]